血管内介入治疗Budd-Chiair综合征疗效分析

Analysis of endovascular therapy for Budd-Chaiari syndrom

目的探讨血管内介入治疗Budd-Chiair综合征的临床价值。方法回顾分析47例Budd-Chiair综合征病例的介入治疗及临床资料,12例行球囊扩张成形术,33例行球囊扩张成形术加支架置入术,2例穿刺未成功行手术治疗。结果介入治疗成功率95.7%(45/47),患者症状缓解,未出现肺拴塞、出血等严重并发症。45例术后平均随访38个月,5例支架内继发血栓形成,其中1例支架内再次置入支架,4例经溶栓后症状缓解。结论血管内介入治疗布加氏综合征安全有效,应予推广。

Objective To assess the clinical value of endovascular therapy for Budd-Chiari syndrome （BCS）. Methods 47 cases with BCS were retrospectively analysed.there were 12 cases only treated with balloon dilatation angioplasty, 33 cases treated with balloon dilatation angioplasty and placement of stent. 2 cases underwent operations because puncture was failed. Results The successful rate of intravascular interventional therapy was 95.7%（45/47）, and the symptom relieved. No pulmonary embolism and hemorrhage occurred during the procedure of treatment. 45 cases fallowed up for average 38 months, 5 cases showed recurrent superior vena cava obstruction, one case received second stent placement and 4 cases received thrombolytic therapy,and recurrent symptoms relieved. Conclusion Endovascular therapy for BCS was very effective and safe, and deserved to be popularized.